Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · Real-Time Price · USD

2.010

-0.070 (-3.37%)

At close: Feb 27, 2026, 4:00 PM EST

1.700

-0.310 (-15.42%)

Pre-market: Mar 2, 2026, 7:00 AM EST

Alzamend Neuro Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Market Capitalization	8	4	5	53	95	-
Market Cap Growth	29.14%	-10.66%	-90.80%	-44.08%	-	-
Enterprise Value	3	1	5	46	83	-
Last Close Price	2.01	5.94	63.99	738.85	1377.00	-
PB Ratio	1.75	1.10	-1.88	17.42	7.11	-
P/TBV Ratio	1.75	1.10	-	17.42	7.11	-
Debt / Equity Ratio	-	-	-0.12	-	-	0.17
Net Debt / Equity Ratio	-1.02	-0.99	0.03	-1.69	-1.05	-0.79
Net Debt / EBITDA Ratio	0.77	0.89	0.01	0.35	1.14	-
Net Debt / FCF Ratio	0.76	0.57	0.01	0.58	2.09	0.59
Quick Ratio	6.20	6.22	0.12	1.79	12.07	2.16
Current Ratio	6.58	6.58	0.14	2.03	12.37	3.24
Return on Equity (ROE)	-144.76%	-657.17%	-4408.31%	-181.47%	-160.92%	-356.06%
Return on Assets (ROA)	-72.71%	-107.38%	-189.73%	-90.97%	-88.35%	-130.96%
Return on Capital Employed (ROCE)	-134.30%	-113.30%	383.10%	-488.30%	-92.30%	-246.00%
Earnings Yield	-84.64%	-103.51%	-203.75%	-28.04%	-13.03%	-
FCF Yield	-76.58%	-157.47%	-172.40%	-16.82%	-7.08%	-
Buyback Yield / Dilution	-985.74%	-499.67%	-4.07%	-9.45%	-22.64%	-1.96%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q